Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01750554 · ClinicalTrials.gov registry record · NA
The Influence of a Bupivacaine Digital Nerve Block Using Rev G.
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT01750554 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 19 participants.
The verdict
NCT01750554, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The investigators are proposing to continue investigation to improve the accuracy of the SpHb (continuous hemoglobin monitoring device) by administering an intermediate acting digital nerve block in the finger connected to the SpHb, specifically bupivacaine 0.25% in patients undergoing spine surgery. Bupivacaine is FDA approved and in routine use.
Interventions
- OTHER intermediate-acting digital nerve block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2012-12 |
| Est. Completion | 2013-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01750554
The ClinicalTrials.gov registry entry for NCT01750554 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which intermediate-acting digital nerve block is the first listed.
NCT01750554 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01750554 about?
NCT01750554 is a clinical study titled "The Influence of a Bupivacaine Digital Nerve Block Using Rev G.". The investigators are proposing to continue investigation to improve the accuracy of the SpHb (continuous hemoglobin monitoring device) by administering an intermediate acting digital nerve block in the finger connected to the SpHb, specifically bupivacaine 0.25% in patients undergoing spine surgery...
What is the current status of trial NCT01750554?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2012-12. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01750554?
The interventions under investigation include: intermediate-acting digital nerve block (OTHER).
Who is sponsoring clinical trial NCT01750554?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.